In line with AST and ALT, significantly increased CYP2E1 activity was found in the HCC group (Fig. 2d), whereas decreased CYP2E1 activity was found in A allele carriers (Fig. 2e). Here, CYP2E1 is linked to hepatocellular carcinoma.